NASDAQ:PDEX Pro-Dex (PDEX) Stock Price, News & Analysis $47.71 +2.66 (+5.90%) As of 07/3/2025 03:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Pro-Dex Stock (NASDAQ:PDEX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Pro-Dex alerts:Sign Up Key Stats Today's Range$45.18▼$47.9150-Day Range$39.00▼$69.0052-Week Range$17.02▼$70.26Volume27,791 shsAverage Volume35,964 shsMarket Capitalization$155.53 millionP/E Ratio17.04Dividend YieldN/APrice Target$56.00Consensus RatingBuy Company Overview Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California. Read More Pro-Dex Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks49th Percentile Overall ScorePDEX MarketRank™: Pro-Dex scored higher than 49% of companies evaluated by MarketBeat, and ranked 1678th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingBuy Consensus RatingPro-Dex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoveragePro-Dex has only been the subject of 1 research reports in the past 90 days.Read more about Pro-Dex's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth3.00% Earnings GrowthEarnings for Pro-Dex are expected to grow by 3.00% in the coming year, from $2.00 to $2.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Pro-Dex is 17.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.56.Price to Earnings Ratio vs. SectorThe P/E ratio of Pro-Dex is 17.04, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.60.Price to Book Value per Share RatioPro-Dex has a P/B Ratio of 5.28. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Pro-Dex's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.86% of the float of Pro-Dex has been sold short.Short Interest Ratio / Days to CoverPro-Dex has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Pro-Dex has recently increased by 6.21%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPro-Dex does not currently pay a dividend.Dividend GrowthPro-Dex does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.86% of the float of Pro-Dex has been sold short.Short Interest Ratio / Days to CoverPro-Dex has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Pro-Dex has recently increased by 6.21%, indicating that investor sentiment is decreasing significantly. News and Social Media2.6 / 5News SentimentN/A News SentimentPro-Dex has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.Search InterestOnly 1 people have searched for PDEX on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.MarketBeat Follows2 people have added Pro-Dex to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Pro-Dex insiders have not sold or bought any company stock.Percentage Held by Insiders47.50% of the stock of Pro-Dex is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 15.28% of the stock of Pro-Dex is held by institutions.Read more about Pro-Dex's insider trading history. Receive PDEX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter. Email Address PDEX Stock News HeadlinesPro-Dex, Inc. (PDEX) Stock Price, Quote, News & Analysis - Seeking AlphaJune 27, 2025 | seekingalpha.comInvestors Shouldn't Overlook The Favourable Returns On Capital At Pro-Dex (NASDAQ:PDEX)June 23, 2025 | finance.yahoo.comRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to open up a $24 trillion investment opportunity. Making it even bigger than cars, computers, and cell phones... COMBINED. A 33+ year market expert has just revealed how early investors could position themselves today for extraordinary gains from this new wave of A.I. in the coming months and years...July 4 at 2:00 AM | Behind the Markets (Ad)Are Pro-Dex, Inc.'s (NASDAQ:PDEX) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?May 20, 2025 | finance.yahoo.comPro-Dex: Crash After Strong Earnings Leads To A Buying OpportunityMay 5, 2025 | seekingalpha.comHere's Why Pro-Dex (NASDAQ:PDEX) Has Caught The Eye Of InvestorsMay 4, 2025 | uk.finance.yahoo.comWith 38% ownership in Pro-Dex, Inc. (NASDAQ:PDEX), hedge funds investors have a lot riding on the businessMarch 11, 2025 | finance.yahoo.comPro Dex director Cabillot sells shares worth $560,229January 28, 2025 | msn.comSee More Headlines PDEX Stock Analysis - Frequently Asked Questions How have PDEX shares performed this year? Pro-Dex's stock was trading at $46.75 at the beginning of the year. Since then, PDEX stock has increased by 2.1% and is now trading at $47.71. How were Pro-Dex's earnings last quarter? Pro-Dex, Inc. (NASDAQ:PDEX) issued its quarterly earnings data on Thursday, May, 1st. The medical instruments supplier reported $0.98 earnings per share for the quarter, topping analysts' consensus estimates of $0.47 by $0.51. The medical instruments supplier had revenue of $17.41 million for the quarter, compared to the consensus estimate of $17.70 million. Pro-Dex had a trailing twelve-month return on equity of 29.08% and a net margin of 14.61%. How do I buy shares of Pro-Dex? Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pro-Dex own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pro-Dex investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), Adobe (ADBE), ServiceNow (NOW), Arista Networks (ANET) and Jabil (JBL). Company Calendar Last Earnings5/01/2025Today7/04/2025Next Earnings (Estimated)9/04/2025Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED/DENTAL - SUPP Sub-IndustryMedical Equipment Current SymbolNASDAQ:PDEX CIK788920 Webwww.pro-dex.com Phone(949) 769-3200Fax949-769-3281Employees140Year FoundedN/APrice Target and Rating Average Stock Price Target$56.00 High Stock Price Target$56.00 Low Stock Price Target$56.00 Potential Upside/Downside+17.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)$2.80 Trailing P/E Ratio17.04 Forward P/E Ratio23.86 P/E GrowthN/ANet Income$2.13 million Net Margins14.61% Pretax Margin19.32% Return on Equity29.08% Return on Assets16.19% Debt Debt-to-Equity Ratio0.28 Current Ratio2.73 Quick Ratio1.45 Sales & Book Value Annual Sales$53.84 million Price / Sales2.89 Cash Flow$1.01 per share Price / Cash Flow47.05 Book Value$9.03 per share Price / Book5.28Miscellaneous Outstanding Shares3,260,000Free Float1,712,000Market Cap$155.53 million OptionableNot Optionable Beta0.19 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:PDEX) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.